Cameroon vs Chad: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cameroon
1.8%
in 2024
Chad
2.2%
in 2024
Cameroon rank
14th
Chad rank
11th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cameroon
- Chad
How they compare
Chad currently reports 2.2% against 1.8% in Cameroon, a difference of 0.4%.
That makes Chad's figure about 1.2 times Cameroon's.
Across all 10 years both countries report, Chad has been ahead every year.
Cameroon ranks 14th and Chad ranks 11th of 215 countries.
Chad has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 4.1% | 2.1% | Chad |
| 2020s | 2.0% | 3.0% | 1.0% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cameroon or Chad?
- Chad, at 2.2% against 1.8% in Cameroon as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cameroon and Chad?
- 0.4%, with Chad ahead.
- How many years of comparable data are there for Cameroon and Chad?
- 10 years are reported by both, from 2015 to 2024.
- How do Cameroon and Chad rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cameroon ranks 14th and Chad ranks 11th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.